| Name | Title | Contact Details |
|---|
Southern Regional Medical Center (SRMC) is a 331-bed hospital serving Riverdale, Georgia, and the surrounding communities. The hospital is owned by Prime Healthcare, an award winning health system that owns nearly 50 hospitals in 14 states.
Methodist Health System, 3 hospitals, 21 clinic locations, a nursing and allied health college, in Omaha, NE
At Gateway Learning Group, we cultivate learning, language, behavior and social skills for individuals with Autism and other special needs. Using the principles of Applied Behavior Analysis (ABA) we design and implement an individualized therapy program for each child based on his or her particular needs and interests. Our therapists are experienced in a full range of the best treatments available including Verbal Behavior, Pivotal Response Treatments, Discrete Trial Training, and the Early Start Denver Model. To provide comprehensive support for our clients and their families, we also collaborate with educators and health professionals. Most of all, we love working with each child and enjoy sharing in their sense of pride, joy and accomplishment as they succeed.
Heart `n Home Hospice and Palliative Care is a local company established on the rural values of hard work and a foundation of integrity. Family owned and operated, Heart `n Home was established in March of 2004 and became Medicare Certified on June 17, 2004. Our core philosophy is to optimize the quality of life for individuals in the final stages of terminal illness. The Heart `n Home ethic and focus of "doing what`s right" has allowed us to flourish and grow to be one of the leading hospice providers in Idaho and Eastern Oregon. This is the epitome of what Heart `n Home is all about. We strive to do what is right for our patients and families; and treasure the privilege of walking people to the gates of eternity. Heart `n Home has over 160 employees and provides hospice and palliative care services to 11 counties in Idaho and Oregon. We have offices in Fruitland (Corporate Headquarters), Caldwell, Emmett, Meridian, Baker City, La Grande, La Pine, and Bend.
Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.